Opexa Therapeutics to Present at the Aegis Capital Corp. 2013 Healthcare Conference
Published: Sep 27, 2013
Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biotechnology company developing Tcelna®, a patient-specific T-cell immunotherapy for the treatment of multiple sclerosis (MS), today announced that Neil K. Warma, Opexa’s President and Chief Executive Officer, will deliver a corporate presentation at the Aegis Capital Corp. 2013 Healthcare Conference. The conference will be held September 25-28th at The Encore at Wynn Las Vegas.
Help employers find you! Check out all the jobs and post your resume.